UniProt ID | SF3B1_HUMAN | |
---|---|---|
UniProt AC | O75533 | |
Protein Name | Splicing factor 3B subunit 1 | |
Gene Name | SF3B1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1304 | |
Subcellular Localization | Nucleus . Nucleus speckle. During mitosis, transiently dispersed from the nuclear speckles to the cytoplasm. | |
Protein Description | Involved in pre-mRNA splicing as a component of the splicing factor SF3B complex. [PubMed: 27720643 SF3B complex is required for 'A' complex assembly formed by the stable binding of U2 snRNP to the branchpoint sequence (BPS) in pre-mRNA. Sequence independent binding of SF3A/SF3B complex upstream of the branch site is essential, it may anchor U2 snRNP to the pre-mRNA] | |
Protein Sequence | MAKIAKTHEDIEAQIREIQGKKAALDEAQGVGLDSTGYYDQEIYGGSDSRFAGYVTSIAATELEDDDDDYSSSTSLLGQKKPGYHAPVALLNDIPQSTEQYDPFAEHRPPKIADREDEYKKHRRTMIISPERLDPFADGGKTPDPKMNARTYMDVMREQHLTKEEREIRQQLAEKAKAGELKVVNGAAASQPPSKRKRRWDQTADQTPGATPKKLSSWDQAETPGHTPSLRWDETPGRAKGSETPGATPGSKIWDPTPSHTPAGAATPGRGDTPGHATPGHGGATSSARKNRWDETPKTERDTPGHGSGWAETPRTDRGGDSIGETPTPGASKRKSRWDETPASQMGGSTPVLTPGKTPIGTPAMNMATPTPGHIMSMTPEQLQAWRWEREIDERNRPLSDEELDAMFPEGYKVLPPPAGYVPIRTPARKLTATPTPLGGMTGFHMQTEDRTMKSVNDQPSGNLPFLKPDDIQYFDKLLVDVDESTLSPEEQKERKIMKLLLKIKNGTPPMRKAALRQITDKAREFGAGPLFNQILPLLMSPTLEDQERHLLVKVIDRILYKLDDLVRPYVHKILVVIEPLLIDEDYYARVEGREIISNLAKAAGLATMISTMRPDIDNMDEYVRNTTARAFAVVASALGIPSLLPFLKAVCKSKKSWQARHTGIKIVQQIAILMGCAILPHLRSLVEIIEHGLVDEQQKVRTISALAIAALAEAATPYGIESFDSVLKPLWKGIRQHRGKGLAAFLKAIGYLIPLMDAEYANYYTREVMLILIREFQSPDEEMKKIVLKVVKQCCGTDGVEANYIKTEILPPFFKHFWQHRMALDRRNYRQLVDTTVELANKVGAAEIISRIVDDLKDEAEQYRKMVMETIEKIMGNLGAADIDHKLEEQLIDGILYAFQEQTTEDSVMLNGFGTVVNALGKRVKPYLPQICGTVLWRLNNKSAKVRQQAADLISRTAVVMKTCQEEKLMGHLGVVLYEYLGEEYPEVLGSILGALKAIVNVIGMHKMTPPIKDLLPRLTPILKNRHEKVQENCIDLVGRIADRGAEYVSAREWMRICFELLELLKAHKKAIRRATVNTFGYIAKAIGPHDVLATLLNNLKVQERQNRVCTTVAIAIVAETCSPFTVLPALMNEYRVPELNVQNGVLKSLSFLFEYIGEMGKDYIYAVTPLLEDALMDRDLVHRQTASAVVQHMSLGVYGFGCEDSLNHLLNYVWPNVFETSPHVIQAVMGALEGLRVAIGPCRMLQYCLQGLFHPARKVRDVYWKIYNSIYIGSQDALIAHYPRIYNDDKNTYIRYELDYIL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Ubiquitination | --MAKIAKTHEDIEA --CCCCCCCHHHHHH | 54.62 | - | |
21 | Ubiquitination | QIREIQGKKAALDEA HHHHHHCHHHHHHHH | 23.90 | - | |
22 | Ubiquitination | IREIQGKKAALDEAQ HHHHHCHHHHHHHHC | 45.79 | - | |
35 | Phosphorylation | AQGVGLDSTGYYDQE HCCCCCCCCCCCCCC | 28.86 | 26552605 | |
36 | Phosphorylation | QGVGLDSTGYYDQEI CCCCCCCCCCCCCCC | 28.95 | 28796482 | |
38 | Phosphorylation | VGLDSTGYYDQEIYG CCCCCCCCCCCCCCC | 12.17 | 28796482 | |
39 | Phosphorylation | GLDSTGYYDQEIYGG CCCCCCCCCCCCCCC | 16.70 | 28796482 | |
44 | Phosphorylation | GYYDQEIYGGSDSRF CCCCCCCCCCCCCCC | 18.06 | 28796482 | |
47 | Phosphorylation | DQEIYGGSDSRFAGY CCCCCCCCCCCCHHC | 28.22 | 28796482 | |
49 | Phosphorylation | EIYGGSDSRFAGYVT CCCCCCCCCCHHCEE | 30.87 | 28796482 | |
54 | Phosphorylation | SDSRFAGYVTSIAAT CCCCCHHCEEEEEEE | 9.34 | 27251275 | |
56 | Phosphorylation | SRFAGYVTSIAATEL CCCHHCEEEEEEEEC | 13.11 | 28796482 | |
57 | Phosphorylation | RFAGYVTSIAATELE CCHHCEEEEEEEECC | 10.53 | 27251275 | |
61 | Phosphorylation | YVTSIAATELEDDDD CEEEEEEEECCCCCC | 31.89 | 26657352 | |
70 | Phosphorylation | LEDDDDDYSSSTSLL CCCCCCCCCCHHHHC | 19.90 | 28796482 | |
71 | Phosphorylation | EDDDDDYSSSTSLLG CCCCCCCCCHHHHCC | 25.47 | 28796482 | |
72 | Phosphorylation | DDDDDYSSSTSLLGQ CCCCCCCCHHHHCCC | 31.26 | 26657352 | |
73 | Phosphorylation | DDDDYSSSTSLLGQK CCCCCCCHHHHCCCC | 18.97 | 28796482 | |
74 | Phosphorylation | DDDYSSSTSLLGQKK CCCCCCHHHHCCCCC | 25.91 | 28796482 | |
75 | Phosphorylation | DDYSSSTSLLGQKKP CCCCCHHHHCCCCCC | 24.44 | 26552605 | |
81 | Acetylation | TSLLGQKKPGYHAPV HHHCCCCCCCCCCCH | 35.47 | 26051181 | |
81 | Ubiquitination | TSLLGQKKPGYHAPV HHHCCCCCCCCCCCH | 35.47 | - | |
84 | Phosphorylation | LGQKKPGYHAPVALL CCCCCCCCCCCHHHH | 11.88 | 27259358 | |
97 | Phosphorylation | LLNDIPQSTEQYDPF HHCCCCCCCCCCCCC | 28.67 | 28555341 | |
98 | Phosphorylation | LNDIPQSTEQYDPFA HCCCCCCCCCCCCCH | 23.12 | 28796482 | |
101 | Phosphorylation | IPQSTEQYDPFAEHR CCCCCCCCCCCHHCC | 21.25 | 28796482 | |
119 | Phosphorylation | IADREDEYKKHRRTM CCCCHHHHHHHCCEE | 37.34 | 26074081 | |
125 | Phosphorylation | EYKKHRRTMIISPER HHHHHCCEEEECHHH | 16.81 | 30266825 | |
126 | Sulfoxidation | YKKHRRTMIISPERL HHHHCCEEEECHHHC | 2.13 | 21406390 | |
129 | Phosphorylation | HRRTMIISPERLDPF HCCEEEECHHHCCCC | 15.13 | 19664994 | |
141 | 2-Hydroxyisobutyrylation | DPFADGGKTPDPKMN CCCCCCCCCCCCCCC | 63.51 | - | |
141 | Acetylation | DPFADGGKTPDPKMN CCCCCCCCCCCCCCC | 63.51 | 19608861 | |
141 | Ubiquitination | DPFADGGKTPDPKMN CCCCCCCCCCCCCCC | 63.51 | 19608861 | |
142 | Phosphorylation | PFADGGKTPDPKMNA CCCCCCCCCCCCCCH | 35.88 | 29255136 | |
146 | Ubiquitination | GGKTPDPKMNARTYM CCCCCCCCCCHHHHH | 52.76 | - | |
151 | Phosphorylation | DPKMNARTYMDVMRE CCCCCHHHHHHHHHH | 22.31 | 29978859 | |
152 | Phosphorylation | PKMNARTYMDVMREQ CCCCHHHHHHHHHHH | 5.93 | 28796482 | |
157 | Citrullination | RTYMDVMREQHLTKE HHHHHHHHHHHCCHH | 40.03 | - | |
157 | Citrullination | RTYMDVMREQHLTKE HHHHHHHHHHHCCHH | 40.03 | - | |
163 | 2-Hydroxyisobutyrylation | MREQHLTKEEREIRQ HHHHHCCHHHHHHHH | 65.03 | - | |
175 | 2-Hydroxyisobutyrylation | IRQQLAEKAKAGELK HHHHHHHHHHCCCCE | 49.97 | - | |
175 | Acetylation | IRQQLAEKAKAGELK HHHHHHHHHHCCCCE | 49.97 | 25953088 | |
175 | Ubiquitination | IRQQLAEKAKAGELK HHHHHHHHHHCCCCE | 49.97 | - | |
182 | Ubiquitination | KAKAGELKVVNGAAA HHHCCCCEEECCCCC | 39.57 | 20972266 | |
182 (in isoform 1) | Ubiquitination | - | 39.57 | 20972266 | |
190 | Phosphorylation | VVNGAAASQPPSKRK EECCCCCCCCCCCCC | 38.19 | 25159151 | |
194 | Phosphorylation | AAASQPPSKRKRRWD CCCCCCCCCCCCCHH | 52.34 | 29255136 | |
195 | 2-Hydroxyisobutyrylation | AASQPPSKRKRRWDQ CCCCCCCCCCCCHHC | 68.65 | - | |
195 | Acetylation | AASQPPSKRKRRWDQ CCCCCCCCCCCCHHC | 68.65 | 25953088 | |
195 | Methylation | AASQPPSKRKRRWDQ CCCCCCCCCCCCHHC | 68.65 | - | |
195 | Ubiquitination | AASQPPSKRKRRWDQ CCCCCCCCCCCCHHC | 68.65 | - | |
203 | Phosphorylation | RKRRWDQTADQTPGA CCCCHHCCCCCCCCC | 29.72 | 29255136 | |
207 | Phosphorylation | WDQTADQTPGATPKK HHCCCCCCCCCCCCC | 25.00 | 29255136 | |
211 | Phosphorylation | ADQTPGATPKKLSSW CCCCCCCCCCCCCCC | 41.37 | 29255136 | |
213 | 2-Hydroxyisobutyrylation | QTPGATPKKLSSWDQ CCCCCCCCCCCCCCC | 63.09 | - | |
213 | Acetylation | QTPGATPKKLSSWDQ CCCCCCCCCCCCCCC | 63.09 | 26051181 | |
213 | Ubiquitination | QTPGATPKKLSSWDQ CCCCCCCCCCCCCCC | 63.09 | - | |
214 | Sumoylation | TPGATPKKLSSWDQA CCCCCCCCCCCCCCC | 55.60 | - | |
214 | Acetylation | TPGATPKKLSSWDQA CCCCCCCCCCCCCCC | 55.60 | 25953088 | |
214 | Sumoylation | TPGATPKKLSSWDQA CCCCCCCCCCCCCCC | 55.60 | 28112733 | |
214 | Ubiquitination | TPGATPKKLSSWDQA CCCCCCCCCCCCCCC | 55.60 | - | |
216 | Phosphorylation | GATPKKLSSWDQAET CCCCCCCCCCCCCCC | 37.96 | 23927012 | |
217 | Phosphorylation | ATPKKLSSWDQAETP CCCCCCCCCCCCCCC | 45.14 | 23927012 | |
223 | Phosphorylation | SSWDQAETPGHTPSL CCCCCCCCCCCCCCC | 37.27 | 22167270 | |
227 | Phosphorylation | QAETPGHTPSLRWDE CCCCCCCCCCCCCCC | 22.08 | 22167270 | |
229 | Phosphorylation | ETPGHTPSLRWDETP CCCCCCCCCCCCCCC | 31.55 | 22167270 | |
231 | Methylation | PGHTPSLRWDETPGR CCCCCCCCCCCCCCC | 43.04 | 115916605 | |
235 | Phosphorylation | PSLRWDETPGRAKGS CCCCCCCCCCCCCCC | 28.68 | 25159151 | |
240 | Ubiquitination | DETPGRAKGSETPGA CCCCCCCCCCCCCCC | 62.70 | - | |
242 | Phosphorylation | TPGRAKGSETPGATP CCCCCCCCCCCCCCC | 37.28 | 30266825 | |
244 | Phosphorylation | GRAKGSETPGATPGS CCCCCCCCCCCCCCC | 28.81 | 29255136 | |
248 | Phosphorylation | GSETPGATPGSKIWD CCCCCCCCCCCCCCC | 33.81 | 29255136 | |
251 | Phosphorylation | TPGATPGSKIWDPTP CCCCCCCCCCCCCCC | 23.36 | 30266825 | |
252 | Acetylation | PGATPGSKIWDPTPS CCCCCCCCCCCCCCC | 54.45 | 26051181 | |
257 | Phosphorylation | GSKIWDPTPSHTPAG CCCCCCCCCCCCCCC | 34.64 | 23401153 | |
259 | Phosphorylation | KIWDPTPSHTPAGAA CCCCCCCCCCCCCCC | 42.33 | 23401153 | |
261 | Phosphorylation | WDPTPSHTPAGAATP CCCCCCCCCCCCCCC | 21.12 | 25159151 | |
267 | Phosphorylation | HTPAGAATPGRGDTP CCCCCCCCCCCCCCC | 26.24 | 23927012 | |
273 | Phosphorylation | ATPGRGDTPGHATPG CCCCCCCCCCCCCCC | 33.71 | 29255136 | |
278 | Phosphorylation | GDTPGHATPGHGGAT CCCCCCCCCCCCCCC | 24.91 | 29255136 | |
285 | Phosphorylation | TPGHGGATSSARKNR CCCCCCCCCHHHCCC | 26.87 | 23401153 | |
286 | Phosphorylation | PGHGGATSSARKNRW CCCCCCCCHHHCCCC | 22.82 | 23927012 | |
287 | Phosphorylation | GHGGATSSARKNRWD CCCCCCCHHHCCCCC | 27.95 | 25159151 | |
290 | Methylation | GATSSARKNRWDETP CCCCHHHCCCCCCCC | 51.05 | 23748837 | |
296 | Phosphorylation | RKNRWDETPKTERDT HCCCCCCCCCCCCCC | 27.84 | 23401153 | |
298 | Acetylation | NRWDETPKTERDTPG CCCCCCCCCCCCCCC | 71.13 | 26051181 | |
299 | Phosphorylation | RWDETPKTERDTPGH CCCCCCCCCCCCCCC | 37.14 | 22167270 | |
303 | Phosphorylation | TPKTERDTPGHGSGW CCCCCCCCCCCCCCC | 37.07 | 22167270 | |
308 | Phosphorylation | RDTPGHGSGWAETPR CCCCCCCCCCCCCCC | 26.03 | 30266825 | |
313 | Phosphorylation | HGSGWAETPRTDRGG CCCCCCCCCCCCCCC | 15.43 | 23927012 | |
316 | Phosphorylation | GWAETPRTDRGGDSI CCCCCCCCCCCCCCC | 31.11 | 23927012 | |
318 | Methylation | AETPRTDRGGDSIGE CCCCCCCCCCCCCCC | 50.83 | 115916609 | |
322 | Phosphorylation | RTDRGGDSIGETPTP CCCCCCCCCCCCCCC | 35.45 | 23401153 | |
326 | Phosphorylation | GGDSIGETPTPGASK CCCCCCCCCCCCCCC | 27.52 | 29255136 | |
328 | Phosphorylation | DSIGETPTPGASKRK CCCCCCCCCCCCCCC | 41.60 | 29255136 | |
332 | O-linked_Glycosylation | ETPTPGASKRKSRWD CCCCCCCCCCCCCCC | 38.62 | 23301498 | |
332 | Phosphorylation | ETPTPGASKRKSRWD CCCCCCCCCCCCCCC | 38.62 | 29255136 | |
333 | 2-Hydroxyisobutyrylation | TPTPGASKRKSRWDE CCCCCCCCCCCCCCC | 64.41 | - | |
333 | Acetylation | TPTPGASKRKSRWDE CCCCCCCCCCCCCCC | 64.41 | 25953088 | |
333 | Ubiquitination | TPTPGASKRKSRWDE CCCCCCCCCCCCCCC | 64.41 | 21890473 | |
336 | Phosphorylation | PGASKRKSRWDETPA CCCCCCCCCCCCCCH | 42.51 | 27732954 | |
341 | Phosphorylation | RKSRWDETPASQMGG CCCCCCCCCHHHCCC | 22.98 | 29255136 | |
344 | Phosphorylation | RWDETPASQMGGSTP CCCCCCHHHCCCCCC | 23.15 | 23401153 | |
349 | Phosphorylation | PASQMGGSTPVLTPG CHHHCCCCCCCCCCC | 24.65 | 29255136 | |
350 | Phosphorylation | ASQMGGSTPVLTPGK HHHCCCCCCCCCCCC | 22.23 | 29255136 | |
354 | Phosphorylation | GGSTPVLTPGKTPIG CCCCCCCCCCCCCCC | 30.17 | 22167270 | |
358 | Phosphorylation | PVLTPGKTPIGTPAM CCCCCCCCCCCCCCC | 26.50 | 28634298 | |
362 | Phosphorylation | PGKTPIGTPAMNMAT CCCCCCCCCCCCCCC | 14.48 | 25002506 | |
369 | Phosphorylation | TPAMNMATPTPGHIM CCCCCCCCCCCCCCC | 19.54 | 25627689 | |
371 | Phosphorylation | AMNMATPTPGHIMSM CCCCCCCCCCCCCCC | 37.23 | 25002506 | |
377 | Phosphorylation | PTPGHIMSMTPEQLQ CCCCCCCCCCHHHHH | 20.92 | 25159151 | |
379 | Phosphorylation | PGHIMSMTPEQLQAW CCCCCCCCHHHHHHH | 19.16 | 25159151 | |
400 | Phosphorylation | DERNRPLSDEELDAM HCCCCCCCHHHHHHH | 45.73 | 30266825 | |
412 | Phosphorylation | DAMFPEGYKVLPPPA HHHCCCCCCCCCCCC | 9.03 | 23403867 | |
413 | Sumoylation | AMFPEGYKVLPPPAG HHCCCCCCCCCCCCC | 48.42 | - | |
413 | Acetylation | AMFPEGYKVLPPPAG HHCCCCCCCCCCCCC | 48.42 | 25953088 | |
413 | Sumoylation | AMFPEGYKVLPPPAG HHCCCCCCCCCCCCC | 48.42 | 25114211 | |
413 | Ubiquitination | AMFPEGYKVLPPPAG HHCCCCCCCCCCCCC | 48.42 | - | |
421 | Phosphorylation | VLPPPAGYVPIRTPA CCCCCCCCCCCCCCC | 12.73 | 30183078 | |
426 | Phosphorylation | AGYVPIRTPARKLTA CCCCCCCCCCCCCCC | 23.24 | 30266825 | |
430 | Sumoylation | PIRTPARKLTATPTP CCCCCCCCCCCCCCC | 52.90 | 28112733 | |
432 | Phosphorylation | RTPARKLTATPTPLG CCCCCCCCCCCCCCC | 31.36 | 30266825 | |
434 | Phosphorylation | PARKLTATPTPLGGM CCCCCCCCCCCCCCC | 23.59 | 29255136 | |
436 | Phosphorylation | RKLTATPTPLGGMTG CCCCCCCCCCCCCCC | 27.13 | 29255136 | |
442 | Phosphorylation | PTPLGGMTGFHMQTE CCCCCCCCCCEEECC | 39.71 | 30266825 | |
448 | Phosphorylation | MTGFHMQTEDRTMKS CCCCEEECCCCCCCC | 32.07 | 23927012 | |
454 | Ubiquitination | QTEDRTMKSVNDQPS ECCCCCCCCCCCCCC | 51.11 | 21890473 | |
455 | Phosphorylation | TEDRTMKSVNDQPSG CCCCCCCCCCCCCCC | 18.48 | 28348404 | |
461 | Phosphorylation | KSVNDQPSGNLPFLK CCCCCCCCCCCCCCC | 34.38 | 27174698 | |
468 | Acetylation | SGNLPFLKPDDIQYF CCCCCCCCHHHCCHH | 46.94 | 26051181 | |
468 | Sumoylation | SGNLPFLKPDDIQYF CCCCCCCCHHHCCHH | 46.94 | - | |
468 | Ubiquitination | SGNLPFLKPDDIQYF CCCCCCCCHHHCCHH | 46.94 | 21890473 | |
474 | Phosphorylation | LKPDDIQYFDKLLVD CCHHHCCHHHHEEEC | 17.68 | 27174698 | |
477 | Ubiquitination | DDIQYFDKLLVDVDE HHCCHHHHEEECCCC | 33.55 | - | |
485 | Phosphorylation | LLVDVDESTLSPEEQ EEECCCCCCCCHHHH | 30.13 | 30266825 | |
486 | Phosphorylation | LVDVDESTLSPEEQK EECCCCCCCCHHHHH | 29.25 | 30266825 | |
488 | Phosphorylation | DVDESTLSPEEQKER CCCCCCCCHHHHHHH | 30.29 | 29255136 | |
493 | Acetylation | TLSPEEQKERKIMKL CCCHHHHHHHHHHHH | 63.87 | 26051181 | |
493 | Ubiquitination | TLSPEEQKERKIMKL CCCHHHHHHHHHHHH | 63.87 | 21890473 | |
499 | Sumoylation | QKERKIMKLLLKIKN HHHHHHHHHHHHHHC | 39.18 | - | |
499 | Acetylation | QKERKIMKLLLKIKN HHHHHHHHHHHHHHC | 39.18 | 25953088 | |
499 | Sumoylation | QKERKIMKLLLKIKN HHHHHHHHHHHHHHC | 39.18 | - | |
499 | Ubiquitination | QKERKIMKLLLKIKN HHHHHHHHHHHHHHC | 39.18 | 21890473 | |
508 | Phosphorylation | LLKIKNGTPPMRKAA HHHHHCCCCCHHHHH | 33.34 | - | |
517 | Methylation | PMRKAALRQITDKAR CHHHHHHHHHHHHHH | 22.56 | 115916613 | |
541 | Phosphorylation | QILPLLMSPTLEDQE HHHHHHHCCCCCHHH | 18.07 | - | |
554 | Acetylation | QERHLLVKVIDRILY HHHHHHHHHHHHHHH | 33.18 | 19608861 | |
554 | Ubiquitination | QERHLLVKVIDRILY HHHHHHHHHHHHHHH | 33.18 | 21906983 | |
558 | Methylation | LLVKVIDRILYKLDD HHHHHHHHHHHHHHH | 15.08 | 115916617 | |
562 | Acetylation | VIDRILYKLDDLVRP HHHHHHHHHHHHHHH | 41.83 | 19608861 | |
608 | Phosphorylation | AKAAGLATMISTMRP HHHHCHHHHHHHCCC | 21.78 | 20068231 | |
611 | Phosphorylation | AGLATMISTMRPDID HCHHHHHHHCCCCCC | 12.82 | 20068231 | |
612 | Phosphorylation | GLATMISTMRPDIDN CHHHHHHHCCCCCCC | 13.28 | 20068231 | |
623 | Phosphorylation | DIDNMDEYVRNTTAR CCCCHHHHHHHHHHH | 10.63 | 20068231 | |
656 | Acetylation | KAVCKSKKSWQARHT HHHHCCCCCHHHHHH | 65.11 | 26051181 | |
700 | 2-Hydroxyisobutyrylation | GLVDEQQKVRTISAL CCCCHHHHHHHHHHH | 33.12 | - | |
700 | Acetylation | GLVDEQQKVRTISAL CCCCHHHHHHHHHHH | 33.12 | 25953088 | |
700 | Ubiquitination | GLVDEQQKVRTISAL CCCCHHHHHHHHHHH | 33.12 | 21890473 | |
733 | Ubiquitination | SVLKPLWKGIRQHRG HHHHHHHHHHHHHCC | 52.74 | - | |
757 | Sulfoxidation | IGYLIPLMDAEYANY HHHHHHHCCHHHHCC | 3.73 | 28183972 | |
761 | Phosphorylation | IPLMDAEYANYYTRE HHHCCHHHHCCCHHH | 11.23 | - | |
764 | Phosphorylation | MDAEYANYYTREVML CCHHHHCCCHHHHHH | 9.68 | - | |
785 | 2-Hydroxyisobutyrylation | QSPDEEMKKIVLKVV CCCCHHHHHHHHHHH | 42.50 | - | |
785 | Acetylation | QSPDEEMKKIVLKVV CCCCHHHHHHHHHHH | 42.50 | 26051181 | |
785 | Ubiquitination | QSPDEEMKKIVLKVV CCCCHHHHHHHHHHH | 42.50 | 21890473 | |
790 | Acetylation | EMKKIVLKVVKQCCG HHHHHHHHHHHHHHC | 33.80 | 25953088 | |
790 | Malonylation | EMKKIVLKVVKQCCG HHHHHHHHHHHHHHC | 33.80 | 26320211 | |
790 | Ubiquitination | EMKKIVLKVVKQCCG HHHHHHHHHHHHHHC | 33.80 | - | |
793 | Acetylation | KIVLKVVKQCCGTDG HHHHHHHHHHHCCCC | 40.37 | 26051181 | |
793 | Ubiquitination | KIVLKVVKQCCGTDG HHHHHHHHHHHCCCC | 40.37 | 21890473 | |
805 | Phosphorylation | TDGVEANYIKTEILP CCCCHHHEEEHHCCC | 15.73 | 25367160 | |
808 | Phosphorylation | VEANYIKTEILPPFF CHHHEEEHHCCCHHH | 20.78 | 19664995 | |
816 | Acetylation | EILPPFFKHFWQHRM HCCCHHHHHHHHHHH | 37.97 | 25953088 | |
816 | Ubiquitination | EILPPFFKHFWQHRM HCCCHHHHHHHHHHH | 37.97 | 21890473 | |
843 | 2-Hydroxyisobutyrylation | TTVELANKVGAAEII HHHHHHHHHCHHHHH | 36.12 | - | |
851 | Phosphorylation | VGAAEIISRIVDDLK HCHHHHHHHHHHHHH | 22.93 | 20068231 | |
858 | 2-Hydroxyisobutyrylation | SRIVDDLKDEAEQYR HHHHHHHHHHHHHHH | 61.59 | - | |
858 | Acetylation | SRIVDDLKDEAEQYR HHHHHHHHHHHHHHH | 61.59 | 26051181 | |
858 | Ubiquitination | SRIVDDLKDEAEQYR HHHHHHHHHHHHHHH | 61.59 | - | |
866 | 2-Hydroxyisobutyrylation | DEAEQYRKMVMETIE HHHHHHHHHHHHHHH | 30.80 | - | |
866 | Ubiquitination | DEAEQYRKMVMETIE HHHHHHHHHHHHHHH | 30.80 | - | |
871 | Phosphorylation | YRKMVMETIEKIMGN HHHHHHHHHHHHHHH | 19.15 | 29759185 | |
874 | Ubiquitination | MVMETIEKIMGNLGA HHHHHHHHHHHHCCC | 33.86 | - | |
876 | Sulfoxidation | METIEKIMGNLGAAD HHHHHHHHHHCCCCC | 4.27 | 28183972 | |
926 | Acetylation | NALGKRVKPYLPQIC HHHHHCCCCCHHHHH | 31.79 | 26051181 | |
926 | Ubiquitination | NALGKRVKPYLPQIC HHHHHCCCCCHHHHH | 31.79 | - | |
956 | Phosphorylation | QQAADLISRTAVVMK HHHHHHHHHHHHHHH | 30.76 | 24850871 | |
963 | 2-Hydroxyisobutyrylation | SRTAVVMKTCQEEKL HHHHHHHHHHHHHHH | 34.24 | - | |
963 | Acetylation | SRTAVVMKTCQEEKL HHHHHHHHHHHHHHH | 34.24 | 25953088 | |
963 | Ubiquitination | SRTAVVMKTCQEEKL HHHHHHHHHHHHHHH | 34.24 | - | |
1008 | Acetylation | VNVIGMHKMTPPIKD HHHHCHHCCCCCHHH | 35.26 | 25953088 | |
1008 | Ubiquitination | VNVIGMHKMTPPIKD HHHHCHHCCCCCHHH | 35.26 | 21890473 | |
1014 | Ubiquitination | HKMTPPIKDLLPRLT HCCCCCHHHHHHHHH | 48.36 | 21890473 | |
1021 | Phosphorylation | KDLLPRLTPILKNRH HHHHHHHHHHHHCHH | 15.01 | 27050516 | |
1025 | Acetylation | PRLTPILKNRHEKVQ HHHHHHHHCHHHHHH | 53.29 | 25953088 | |
1025 | Ubiquitination | PRLTPILKNRHEKVQ HHHHHHHHCHHHHHH | 53.29 | 21890473 | |
1030 | 2-Hydroxyisobutyrylation | ILKNRHEKVQENCID HHHCHHHHHHHHHHH | 42.99 | - | |
1030 | Acetylation | ILKNRHEKVQENCID HHHCHHHHHHHHHHH | 42.99 | 26051181 | |
1030 | Ubiquitination | ILKNRHEKVQENCID HHHCHHHHHHHHHHH | 42.99 | - | |
1035 | Glutathionylation | HEKVQENCIDLVGRI HHHHHHHHHHHHHHH | 2.23 | 22555962 | |
1045 | Methylation | LVGRIADRGAEYVSA HHHHHHHCCCHHCCH | 36.88 | 115916597 | |
1059 | S-nitrosylation | AREWMRICFELLELL HHHHHHHHHHHHHHH | 1.21 | 22178444 | |
1059 | S-palmitoylation | AREWMRICFELLELL HHHHHHHHHHHHHHH | 1.21 | 29575903 | |
1067 | Acetylation | FELLELLKAHKKAIR HHHHHHHHHHHHHHH | 62.15 | 25825284 | |
1080 | Phosphorylation | IRRATVNTFGYIAKA HHHHCCHHHHHHHHH | 17.69 | 28152594 | |
1083 | Phosphorylation | ATVNTFGYIAKAIGP HCCHHHHHHHHHHCH | 8.10 | 28152594 | |
1102 | Acetylation | ATLLNNLKVQERQNR HHHHHHHCHHHHHCC | 43.95 | 26051181 | |
1102 | Ubiquitination | ATLLNNLKVQERQNR HHHHHHHCHHHHHCC | 43.95 | 21890473 | |
1136 | Phosphorylation | LPALMNEYRVPELNV HHHHHHHCCCCCHHH | 16.35 | 22817900 | |
1170 | Phosphorylation | KDYIYAVTPLLEDAL CHHEEEECHHHHHHH | 10.47 | - | |
1180 | Methylation | LEDALMDRDLVHRQT HHHHHCCCCHHHHHH | 25.79 | 115916601 | |
1269 | Phosphorylation | RDVYWKIYNSIYIGS HHHHHHHHCCEEECC | 10.10 | 28152594 | |
1271 | Phosphorylation | VYWKIYNSIYIGSQD HHHHHHCCEEECCCC | 10.37 | 28152594 | |
1273 | Phosphorylation | WKIYNSIYIGSQDAL HHHHCCEEECCCCCC | 10.07 | 28152594 | |
1288 | Phosphorylation | IAHYPRIYNDDKNTY EECCCEEEECCCCEE | 17.51 | 28152594 | |
1292 | 2-Hydroxyisobutyrylation | PRIYNDDKNTYIRYE CEEEECCCCEEEEEE | 54.79 | - | |
1292 | Acetylation | PRIYNDDKNTYIRYE CEEEECCCCEEEEEE | 54.79 | 26051181 | |
1292 | Ubiquitination | PRIYNDDKNTYIRYE CEEEECCCCEEEEEE | 54.79 | 21890473 | |
1294 | Phosphorylation | IYNDDKNTYIRYELD EEECCCCEEEEEEEE | 26.51 | 28152594 | |
1295 | Phosphorylation | YNDDKNTYIRYELDY EECCCCEEEEEEEEE | 7.87 | 28152594 | |
1302 | Phosphorylation | YIRYELDYIL----- EEEEEEEECC----- | 19.42 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
142 | T | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
211 | T | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
244 | T | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
248 | T | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
273 | T | Phosphorylation | Kinase | DYRK1A | Q13627 | PSP |
313 | T | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
354 | T | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
426 | T | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
434 | T | Phosphorylation | Kinase | DYRK1A | Q13627 | PSP |
434 | T | Phosphorylation | Kinase | DYR1B | Q9Y463 | PhosphoELM |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SF3B1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-141; LYS-554 AND LYS-562,AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-129; THR-207; THR-211;THR-223; THR-227; THR-326; SER-332; THR-341; SER-349; THR-350;SER-400; THR-434 AND THR-436, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-194; THR-207; THR-211;THR-267; THR-273; SER-322; THR-326; THR-328; SER-349; THR-350; THR-354AND SER-488, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-129; THR-142; SER-194;THR-207; THR-211; THR-223; THR-227; THR-235; THR-326; THR-328; SER-332AND SER-488, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-211; THR-354 ANDSER-488, AND MASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-344; THR-350 ANDTHR-354, AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-223; THR-227; THR-257;THR-261; THR-267; THR-299 AND THR-432, AND MASS SPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-142; THR-223 ANDTHR-244, AND MASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-207; THR-211; THR-326AND THR-328, AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-211; THR-223; THR-296;THR-299; THR-316 AND THR-326, AND MASS SPECTROMETRY. | |
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells."; Kim J.-E., Tannenbaum S.R., White F.M.; J. Proteome Res. 4:1339-1346(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-235, AND MASSSPECTROMETRY. | |
"Phosphorylation-dependent interaction between the splicing factorsSAP155 and NIPP1."; Boudrez A., Beullens M., Waelkens E., Stalmans W., Bollen M.; J. Biol. Chem. 277:31834-31841(2002). Cited for: INTERACTION WITH PPP1R8, PHOSPHORYLATION AT THR-244; THR-248 ANDTHR-313, AND MUTAGENESIS OF THR-223; THR-227; THR-235; THR-244;THR-248; THR-257; THR-261; THR-267; THR-273; THR-278; THR-296; THR-303AND THR-313. |